Extensive evidence indicates that the (Nucleotide-binding domain, Leucine-Rich – containing family, Pyrin domain – containing-3) NLRP3 inflammasome plays a dual role in CRC, influencing tumor progression, prognosis, and treatment response while also contributing to tumor suppression by regulating host immunity. This evidence concerns the gene NLRP3 and colorectal carcinoma.